Posts By: Rory O'Connor

Feinstein Institute, NIH launch groundbreaking clinical trial for new lupus medication

Posted

Trial examines use of synthetic endocannabinoid mimetic with no psychotropic properties to treat lupus inflammation MANHASSET, NY – Researchers at Northwell Health’s Feinstein Institute for Medical Research are leading a nationwide National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) sponsored clinical trial testing the efficacy of a synthetic cannabinoid derivative… read more

posted in: Press Releases